Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-11-13
1998-05-05
Powers, Fiona T.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
549433, A61K 3136, C07D31770
Patent
active
057475296
ABSTRACT:
Antineoplastic cyclolignan derivatives are of formula (I): ##STR1## in which Ar is a 3,4,5-trialkoxyphenyl or 4-hydroxy-3,5-dialkoxyphenyl; X is an oxygen, sulphur or nitrogen atom, a methine group .dbd.CH-- or an alkylmethine group .dbd.C(alkyl)--; Y is a hydrogen atom or an alkyl, alkenyl, (poly)haloalkyl, aryl, hydroxy, alkoxy, amino, monoalkylamino, dialkylamino, (poly)haloalkylamino, arylamino, acyl or acetamido group, or the group Y is absent; Z is an alkyl, hydroxyalkyl, acyl, carboxy, alkoxycarbonyl or aryloxycarbonyl group; and the dotted lines indicate one double bond located at position .DELTA..sup.7-8 or .DELTA..sup.8-8'.
REFERENCES:
patent: 5011948 (1991-04-01), Vyas et al.
Hartwell and Schrecker, "The Chemistry of Podophyllum", Progress in the Chemistry of Organic Natural Products, pp. 84-166, 1957.
Terada et al., "Antitumor Agents. I. DNA Topoisomerase II Inhibitory Activity and the Structural Relationship of Podophyllotoxin Derivatives as Antitumor Agents", Chem. Pharm. Bull., 40(10) 2720-2727, 1992.
Thurston et al., "Antitumor Agents. 78. Inhibition of Human DNA Topoisomerase II by Podophyllotoxin and .alpha.-Peltatin Analogues", J. Med. Chem., 29:1547-1550, 1986.
Jones et al., J. Chem. Soc., Perkin Trans. 1, 21, 2541-2548, 1993.
Jones et al., J. Chem. Soc., Perkin Trans. 1, 2, 151-155, 1996.
Rai et al., Chemical Abstracts, 105:16458d, 1986.
Rai et al., Current Science, 55(15), 702-706 (1986).
Castro Maria Angeles
del Corral Jose Maria Migel
Gordaliza Marina
Gravalos Dolores G.
Lopez Maria Luisa
Linek Ernest V.
Powers Fiona T.
Universidad de Salamanca
LandOfFree
Antineoplastic cyclolignan derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antineoplastic cyclolignan derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antineoplastic cyclolignan derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-55201